Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM11A-31-BHS 600 mg twice daily in healthy elderly volunteers
2018-001071-20Phase 2Completed
- Sponsor
- PharmatrophiX, Inc.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LM11A-31 in Alzheimer's disease (AD), sponsored by PharmatrophiX, Inc.. Started Jul 2018; status: completed.
02
Drugs
LM11A-31
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2018-001071-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001071-20.